TY  - RPRT
TI  - Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
AU  - Sherif S Farag
AU  - Stephen L George
AU  - Edward J Lee
AU  - Maria Baer
AU  - Richard K Dodge
AU  - Brian Becknell
AU  - Todd A Fehniger
AU  - Lewis R Silverman
AU  - Jeffrey Crawford
AU  - Clara D Bloomfield
AU  - Richard A Larson
AU  - Charles A Schiffer
AU  - Michael A Caligiuri
PY  - 2002
UR  - https://pubmed.ncbi.nlm.nih.gov/12231521/
ID  - 12231521
ER  -